APA (7th ed.) Citation

Georgiou, A., Stewart, A., Vlachogiannis, G., Pickard, L., Valeri, N., Cunningham, D., . . . Banerji, U. (2021). A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAFV600 wild-type colorectal cancer. Cellular Oncology (2211-3428), 44(5), 1197. https://doi.org/10.1007/s13402-021-00628-7

Chicago Style (17th ed.) Citation

Georgiou, Alexandros, Adam Stewart, Georgios Vlachogiannis, Lisa Pickard, Nicola Valeri, David Cunningham, Steven R. Whittaker, and Udai Banerji. "A Phospho-proteomic Study of Cetuximab Resistance in KRAS/NRAS/BRAFV600 Wild-type Colorectal Cancer." Cellular Oncology (2211-3428) 44, no. 5 (2021): 1197. https://doi.org/10.1007/s13402-021-00628-7.

MLA (9th ed.) Citation

Georgiou, Alexandros, et al. "A Phospho-proteomic Study of Cetuximab Resistance in KRAS/NRAS/BRAFV600 Wild-type Colorectal Cancer." Cellular Oncology (2211-3428), vol. 44, no. 5, 2021, p. 1197, https://doi.org/10.1007/s13402-021-00628-7.